Michael Hunter, MD
Pain Medicine · San Antonio, TXNPI 1528447521
Payments from drug & device makers
Across 384 payments — averaging $42.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$8K
- Boston Scientific$2K
- Si-bone, Inc.$2K
- Medtronic$540
- Zavation Medical Products, LLC$500
- Nalu Medical, Inc.$451
- plus $3K from 29 others
What the payments were for
- Consulting fees$5003%
- Travel & lodging$1,83711%
- Food & beverage$13,91585%
- Education$1241%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 176 | $7,914 |
| Boston Scientific | 34 | $2,210 |
| Si-bone, Inc. | 22 | $1,691 |
| Medtronic(2 entities) | 16 | $540 |
| Zavation Medical Products, LLC | 1 | $500 |
| Nalu Medical, Inc. | 9 | $451 |
| Stimwave Technologies Incorporated | 9 | $344 |
| Nevro Corp. | 11 | $332 |
| Genesys Orthopedics Systems, L.L.C. | 3 | $322 |
| Collegium Pharmaceutical, Inc. | 25 | $282 |
| Globus Medical | 7 | $256 |
| Scilex Pharmaceuticals Inc. | 12 | $183 |
| AbbVie | 9 | $180 |
| Averitas Pharma Inc. | 8 | $165 |
| Painteq LLC | 3 | $141 |
| Curonix LLC | 2 | $137 |
| Biodelivery Sciences International, Inc. | 7 | $96 |
| Vertos Medical, Inc. | 1 | $84 |
| Biotronik NRO, Inc. | 2 | $58 |
| Tersera Therapeutics LLC | 2 | $55 |
| Teva Pharmaceuticals USA, Inc. | 3 | $52 |
| Pfizer | 3 | $48 |
| Vertex | 2 | $47 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $38 |
| Valinor Pharma, LLC | 2 | $37 |
| GRT US Holding, Inc. | 2 | $32 |
| IBSA Pharma Inc. | 2 | $29 |
| Stryker | 1 | $28 |
| Electromed, Inc. | 2 | $27 |
| Johnson & Johnson | 1 | $21 |
| Fidia Pharma USA Inc. | 1 | $19 |
| SPR Therapeutics, Inc | 1 | $18 |
| Bioventus LLC | 1 | $18 |
| Saluda Medical Americas, Inc. | 1 | $13 |
| MML US, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Proclaim Family of SCS IPGs$1,501
- PROCLAIM$1,261
- iFuse Implant$1,073
- SPECTRA WAVEWRITER$1,037
- Proclaim IPG$530
- ETERNA$381
- Nalu Neurostimulation System$349
- IonicRF$247
- StimQ Receiver Stimulator Kit Channel A US w Receiver$218
- StimQ Freedom-4A Receiver Kit Channel A US w/ Receiver$218
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$218
- Freedom 4A Receiver Kit Channel A US w Receiver$218
- Freedom 8A Receiver Kit Channel A US w Receiver$218
- Penta SCS Leads$155
- NT1100 NT2000iX Simplicity$151
- Senza$140
- Vyrsa V1$138
- INTELLIS$134
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$124
- INTELLIS ADAPTIVESTIM$120
How this compares
$16,376 in reported general payments places this provider in the 80th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 137 | $99,809 |
| Buprenorphine | 267 | $68,957 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,393 | $49,194 |
| Xtampza ErOxycodone Myristate | 85 | $26,525 |
| MovantikNaloxegol Oxalate | 27 | $20,440 |
| Pregabalin | 621 | $11,084 |
| Celecoxib | 314 | $8,550 |
| Tramadol Hcl ErTramadol Hcl | 128 | $6,901 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 208 | $6,033 |
| Lidocaine | 57 | $4,655 |
| Duloxetine Hcl | 107 | $4,358 |
| Diclofenac Sodium | 233 | $3,923 |
| Buprenorphine Hcl | 156 | $3,307 |
| Naloxone Hcl | 44 | $2,829 |
| Tramadol Hcl | 281 | $2,483 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $282 | $126,334222 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 583 pain medicine providers in Texas.
Other pain medicine in San Antonio
- Ellen LinSan Antonio$251K
- Theresia LeeSan Antonio$104K
- Prabhdeep GrewalSan Antonio$48K
- Roberto DiazSan Antonio$37K
- Charles BryantSan Antonio$28K
- Aaron CalodneyTyler$3M
- Mitchell EngleHouston$1.5M
- Melissa MurphyGrapevine$711K
- Shiraz YazdaniLubbock$632K
- Muhammad ZulqarnainDallas$556K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.